BusinessNovan Announces Preclinical Data Demonstrating Immunomodulatory Effect In VivoBy Nasdaq OMXNov 16, 2016, 2:05 PM UTC
BusinessNovan to Present Data from SB204 Phase 2b Trial at Fall Clinical Dermatology ConferenceBy Nasdaq OMXOct 18, 2016, 1:05 PM UTC